Hudson Bay Capital Management »

Acumen Pharmaceuticals shares owned by Hudson Bay Capital Management

Quarter-by-quarter ownership of Acumen Pharmaceuticals (ABOS) shares owned by Hudson Bay Capital Management from 13F filings

Historical chart of Hudson Bay Capital Management investment in Acumen Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Acumen Pharmaceuticals held by Hudson Bay Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acumen Pharmaceuticals by Hudson Bay Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $1.6M 670k 2.42
2024-03-31 $2.3M 560k 4.05
2023-12-31 $2.2M 564k 3.84
2023-09-30 $2.2M 525k 4.15
2023-06-30 $1.9M 395k 4.81
2023-03-31 $1.4M 357k 4.06
2022-12-31 $1.3M 240k 5.40

More positions owned by Hudson Bay Capital Management

NVIDIA Corporation Call Option (NVDA)
Amazon Call Option (AMZN)
Microsoft Corporation Call Option (MSFT)
Apple Call Option (AAPL)
Eli Lilly & Co. Put Option (LLY)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Dollar Tree Put Option (DLTR)
Brookfield Corp Cl A Ltd Vt Sh Put Option (BN)
Taiwan Semiconductor Mfg Sponsored Ads Put Option (TSM)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Advanced Micro Devices Put Option (AMD)
Royal Caribbean Group Note 6.000% 8/1 (Principal)
Meta Platforms Cl A Put Option (META)
Broadcom Put Option (AVGO)
Boeing Company Put Option (BA)

View all positions for Hudson Bay Capital Management

Top funds holding Acumen Pharmaceuticals

RA Capital Management
Franklin Resources
Rock Springs Capital Management
BlackRock
Millennium Management
Vanguard Group
Laurion Capital Management
T. Rowe Price Associates
Alyeska Investment Group
Geode Capital Management
Hudson Bay Capital Management
Pathstone Holdings
State Street Corporation
Jane Street
Two Sigma Advisers

View all funds holding Acumen Pharmaceuticals